Beranda600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Tutup sebelumnya
¥3,72
Rentang hari
¥3,67 - ¥3,75
Rentang tahun
¥3,06 - ¥4,97
Kapitalisasi pasar
9,17 M CNY
Volume Rata-Rata
41,59 jt
Rasio P/E
20,86
Hasil dividen
-
Bursa utama
SHA
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 3,90 M | -5,29% |
Biaya operasional | 838,57 jt | 2,13% |
Penghasilan bersih | 68,89 jt | -58,22% |
Margin laba bersih | 1,77 | -55,86% |
Penghasilan per saham | — | — |
EBITDA | 166,37 jt | -50,19% |
Tarif pajak efektif | 34,67% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,74 M | -12,32% |
Total aset | 14,08 M | -1,31% |
Total liabilitas | 7,67 M | -7,75% |
Total ekuitas | 6,41 M | — |
Saham yang beredar | 2,52 M | — |
Harga terhadap nilai buku | 1,65 | — |
Tingkat pengembalian aset | 2,00% | — |
Tingkat pengembalian modal | 3,67% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 68,89 jt | -58,22% |
Kas dari operasi | -192,48 jt | -283,26% |
Kas dari investasi | -54,77 jt | -55,00% |
Kas dari pembiayaan | -88,11 jt | 49,20% |
Perubahan kas bersih | -334,93 jt | -222,01% |
Arus kas bebas | -402,50 jt | -471,06% |
Tentang
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Didirikan
1988
Situs
Karyawan
10.180
